Xynos Konstantinos, Chief Medical Officer of Replimune Group, Inc. ($REPL), made two open market sales of company shares over the past year, totaling $130,000. His most recent sale occurred on November 17, 2025. These transactions rank 9,193rd among 11,678 individual insiders in our database by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Konstantinos recorded no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | A | Common Stock | 60000 | $0.00 | 199,685.0000 | 91,915,769 | 42.95% | 0.07% |
| Nov. 17, 2025 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | S | Common Stock | 7248 | $9.10 | 139,685.0000 | 91,915,769 | 4.93% | 0.01% |
| May 20, 2025 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | S | Common Stock | 7952 | $8.06 | 146,933.0000 | 80,564,147 | 5.13% | 0.01% |
| April 1, 2025 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 67500 | $0.00 | 67,500.0000 | 80,564,147 | 9999.99% | 0.08% |
| April 1, 2025 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | A | Common Stock | 45000 | $0.00 | 154,885.0000 | 80,564,147 | 40.95% | 0.06% |
| Nov. 18, 2024 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | S | Common Stock | 7246 | $10.78 | 109,885.0000 | 78,570,135 | 6.19% | 0.01% |
| June 7, 2024 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | S | Common Stock | 15881 | $7.50 | 117,131.0000 | 66,569,894 | 11.94% | 0.02% |
| May 16, 2024 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | S | Common Stock | 6367 | $6.47 | 133,012.0000 | 66,569,894 | 4.57% | 0.01% |
| April 1, 2024 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | A | Common Stock | 26665 | $0.00 | 139,379.0000 | 66,569,894 | 23.66% | 0.04% |
| April 1, 2024 | Replimune Group, Inc. | $REPL | Xynos Konstantinos | Chief Medical Officer | A | Employee Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 66,569,894 | 9999.99% | 0.12% |